503 Durability of HBeAg seroconversion following adefovir dipivoxil treatment for chronic hepatitis B (CHB)
T.T. Chang, M.L. Shiffman, M. Tong, Y.E. Liaw, P. Komolmit, J. Sorbel, S. Arterburn, E. Mondou, S. Chuck, P. MarcellinVolume:
44
Year:
2006
Language:
english
DOI:
10.1016/s0168-8278(06)80503-9
File:
PDF, 136 KB
english, 2006